The TME supports tumor growth through angiogenesis, immune evasion, and modifying drug responses, playing a critical role in immunotherapy tolerance by mechanisms such as cytokine secretion (e.g., TGF-β, IL-10) that suppress immune responses, and the expression of checkpoint molecules like PD-L1 that help tumors evade immune detection (32). Here, CD274 is linked to neoplasm.